Paper39149142
Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Leng X and 11 others. J Pharm Anal, 2024. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Non-coding RNAs as therapeutic targets in cancer and its clinical application. Papers, record 39149142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39149142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References489
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32532962 | Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32532962 | PubMed |
| 2 | 28435295 | Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7. | Onco Targets Ther | 2017 | https://conductscience.org/library/papers/28435295 | PubMed |
| 3 | 17898713 | Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. | Nature | 2007 | https://conductscience.org/library/papers/17898713 | PubMed |
| 4 | 33543830 | Circ-UBAP2 functions as sponges of miR-1205 and miR-382 to promote glioma progression by modulating STC1 expression. | Cancer Med | 2021 | https://conductscience.org/library/papers/33543830 | PubMed |
| 5 | 30621700 | The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30621700 | PubMed |
| 6 | 34238213 | LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. | Cell Mol Biol Lett | 2021 | https://conductscience.org/library/papers/34238213 | PubMed |
| 7 | 19818597 | MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19818597 | PubMed |
| 8 | 32869873 | Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex. | Hepatology | 2021 | https://conductscience.org/library/papers/32869873 | PubMed |
| 9 | 29449673 | The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29449673 | PubMed |
| 10 | 31062668 | M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. | Cancer Biol Ther | 2019 | https://conductscience.org/library/papers/31062668 | PubMed |
| 11 | 18474035 | RNAi mechanisms and applications. | Biotechniques | 2008 | https://conductscience.org/library/papers/18474035 | PubMed |
| 12 | 32821115 | CircHIPK3 Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Cells Proliferation and Metastasis via Altering of miR-508-3p/CXCL13 Signal. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32821115 | PubMed |
| 13 | 24379988 | Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. | Cancer Biol Med | 2013 | https://conductscience.org/library/papers/24379988 | PubMed |
| 14 | 19671678 | miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. | Mol Cancer Res | 2009 | https://conductscience.org/library/papers/19671678 | PubMed |
| 15 | 24813230 | Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. | Cell Mol Immunol | 2014 | https://conductscience.org/library/papers/24813230 | PubMed |
| 16 | 24843008 | p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. | Elife | 2014 | https://conductscience.org/library/papers/24843008 | PubMed |
| 17 | 31625175 | Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. | J Cell Biochem | 2020 | https://conductscience.org/library/papers/31625175 | PubMed |
| 18 | 31270953 | Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/31270953 | PubMed |
| 19 | 31593800 | Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. | Cancer Lett | 2020 | https://conductscience.org/library/papers/31593800 | PubMed |
| 20 | 30208739 | Roles of miR-200 family members in lung cancer: more than tumor suppressors. | Future Oncol | 2018 | https://conductscience.org/library/papers/30208739 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42885288 | miR‑324‑5p in oncology: Molecular mechanisms and clinical outlook (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/42885288 | PubMed |
| 42737737 | The hsa_circ_0084050/miR-373-3p Axis Controls Bone Sialoprotein-Induced ADAM9 Upregulation to Drive Lung Cancer Progression and Metastasis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737737 | PubMed |
| 42348295 | A Primate-Specific lncRNA LINC01021 Contributes to Cellular and Organismal Aging via DAZAP1-Dependent Destabilization of RBMX. | Aging Cell | 2026 | https://conductscience.org/library/papers/42348295 | PubMed |
| 42246151 | LINC01117 promotes the malignant proliferation of lung adenocarcinoma by increasing HOXD8 mRNA stability. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42246151 | PubMed |
| 42035369 | Identification of hsa-miR-144-3p as a novel immunotherapeutic target for glioblastoma based on disulfidptosis-related analysis. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42035369 | PubMed |
| 41907432 | Regulatory BC200 RNA promotes breast carcinogenesis by repressing BRCA1 gene expression. | iScience | 2026 | https://conductscience.org/library/papers/41907432 | PubMed |
| 41479036 | Epigenetic Modulation of Immunity: Mechanisms, Implications, and Emerging Therapeutic Horizons; a Step Toward Epigenetics to Precision. | Subcell Biochem | 2026 | https://conductscience.org/library/papers/41479036 | PubMed |
| 41108105 | Epithelial-mesenchymal-associated non-coding RNAs as Breast cancer metastasis biomarkers. | Cell Cycle | 2025 | https://conductscience.org/library/papers/41108105 | PubMed |
| 41020915 | Unveiling the oncogenic functions of lncRNA PSMG3-AS1: a review of its biological roles in cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41020915 | PubMed |
| 40869000 | The Interplay Between Oxidant/Antioxidant System, Transcription Factors, and Non-Coding RNA in Lung Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869000 | PubMed |
| 40553231 | Exosomal long non-coding RNAs in human malignancies: biological functions and clinical applications. | Med Oncol | 2025 | https://conductscience.org/library/papers/40553231 | PubMed |
| 40281701 | Current Research in Drug-Free Cancer Therapies. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40281701 | PubMed |
| 40257717 | Direct oral anticoagulants do not affect miR-27a-3p expression, a regulator of coagulation cascade, in atrial fibrillation patients. | J Thromb Thrombolysis | 2025 | https://conductscience.org/library/papers/40257717 | PubMed |
| 40255569 | MiR-3613-5p targets AQP4 to promote the progression of chronic atrophic gastritis to gastric cancer. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40255569 | PubMed |
| 40202675 | Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40202675 | PubMed |
| 40202565 | Interplay between LncRNAs and autophagy-related pathways in leukemia: mechanisms and clinical implications. | Med Oncol | 2025 | https://conductscience.org/library/papers/40202565 | PubMed |
| 40046513 | The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/40046513 | PubMed |
| 40006021 | Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40006021 | PubMed |
| 39849644 | Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms. | Biomark Res | 2025 | https://conductscience.org/library/papers/39849644 | PubMed |
| 39811361 | Eugenol inhibits NEAT1 as a ceRNA in pre-cancerous breast lesions. | Heliyon | 2025 | https://conductscience.org/library/papers/39811361 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39149142
GET https://conductscience.org/api/papers/v1/39149142/references?page=2